A Lleida review of a research study opens the door to alternative mechanisms in the development of fatty liver disease

by IRB Lleida. Institut de Recerca Biomèdica

2 years ago
EndoG gene, fatty liver disease

The Cell Signalling and Apoptosis research group at UdL and IRBLleida has argued that several of the key findings of Wang's study are not fully supported by the data presented

A link between histidine and fatty liver disease discovered in a study by IDIBGI and Eurecat

by IdiBGi

2 years ago
histidine, fatty liver disease

Researchers at the Institute for Biomedical Research of Girona (IDIBGI) and the Eurecat technology centre have also found that histidine levels are linked to a bacterial species in the gut microbiota....

Promising drug against non-alcoholic steatohepatitis, a severe type of liver disease

by Fundació Bosch i Gimpera

6 years ago
drug, fatty liver disease, plasma, NASH, non-alcoholic steatohepatitis

Nonalcoholic steatohepatitis (NASH) affects 2 to 5 percent of the world’s population. It is the most severe form of fatty liver disease, which can lead to cirrhosis, among other complications, and i...

Researchers discover a protein that protects against fatty liver, the most common hepatic disease in Western countries

by IRB Barcelona - Instituto de Investigación Biomédica

10 years ago
fatty liver disease, liver cells, CPEB4, metabolism, Tudca

It is a disease of the liver caused by excessive fat deposits in liver cells. It is now the most prevalent chronic liver disease in industrialised countries and is a major public health concern becaus...

The stabilization of new lipid mediators derived from omega-3 fatty acids reduces the liver inflammation caused by obesity

by Fundació Clínic per a la Recerca Biomèdica

12 years ago
non-alcoholic steatohepatitis, fatty liver disease

Inhibitors of sEH are suggested as a promising therapeutic strategy to prevent and counteract the consequences of obesity. Based on the significant results obtained in this work new studies will be la...